Terumo Cardiovascular Systems to Distribute Estech CABG Products in the US
Ann Arbor, Michigan — November 11, 2011 — Terumo Cardiovascular Systems announced today that it has entered into an exclusive agreement with Estech Corporation for the distribution of Estech's CABG stabilization and access products in the US. Effective immediately, Terumo will exclusively market, sell and distribute Estech's complete line of CABG products for off-pump, on-pump and endocab procedures in the US.
Estech's unique CABG product line includes a reusable arm and disposable attachments that provide the strongest stabilization and positioning technology in the industry.
Mark Sutter, President and CEO of Terumo Cardiovascular Systems, stated “We are proud to partner with Estech. This expansion of our portfolio of products will allow Terumo to deepen its footprint in the CV surgery space. This partnership is another example of Terumo CVS's concerted effort to expand its offerings to cardiovascular and thoracic surgeons.”
Terumo is a recognized leader in medical devices worldwide with a long history in the cardiac surgery market. Its established and larger sales, distribution and customer service network will immediately expand customer access to Estech CABG products in the US. “This agreement will allow Estech to focus on its strategically important minimally invasive cardiac ablation products,” stated Estech CEO John Pavlidis.
About Terumo Cardiovascular Systems Corporation
Terumo Cardiovascular Systems Corporation manufactures and markets medical devices for the global cardiac surgery market and is the U.S. distributor for Vascutek® Vascular Grafts. The company is headquartered in Ann Arbor, Michigan with manufacturing operations in Ann Arbor; Elkton, Maryland; and Ashland, Massachusetts. It is one of several subsidiaries of Terumo Corporation of Japan, which focus exclusively on cardiac and vascular specialties, including Terumo Heart Inc., developer of a ventricular assist device and Vascutek, Ltd., manufacturer of a broad portfolio of vascular grafts. For more information, visit www.terumo-cvs.com.
Estech develops and markets a broad portfolio of innovative medical devices and disposables that enable cardiac surgeons worldwide to perform a variety of surgical procedures, including the growing trend in minimally invasive and hybrid ablation procedures, with maximum ease of use, patient safety and clinical effectiveness. Estech is privately held and backed by a number of leading life sciences venture capital firms in Silicon Valley and Europe. The company is headquartered in San Ramon, California, USA. For more information, please visit www.estech.com.
Manager, Marketing Communications
Terumo Cardiovascular Systems Corp.